We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

MFC:TSXManulife Financial Corporation Analysis

Data as of 2026-06-02 - not real-time

CA$52.25

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Manulife Financial Corp. is trading above its longer‑term moving averages, indicating a prevailing bullish bias, yet it sits just above a well‑defined support zone and below the short‑term average, suggesting limited upside in the near term. The stock benefits from a price‑to‑earnings multiple that sits comfortably under the sector average and a discounted cash‑flow valuation that points to meaningful upside, while its dividend yield remains attractive with a payout ratio near half of earnings. Technical momentum is mixed: a neutral RSI and an increasing volume trend support the bullish narrative, but a bearish MACD crossover adds short‑term caution. Recent corporate actions, including the decision not to redeem certain preferred shares and the issuance of new subordinated notes, signal disciplined capital management and a focus on liquidity. Overall, the combination of solid cash generation, a strong balance sheet, and a modest beta underscores a relatively low‑volatility profile within the financial services sector.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Price is near a technical support level
  • Bearish MACD signal adds downside pressure
  • Strong dividend yield provides income cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF and peer multiples
  • Revenue and earnings growth outpacing the sector
  • Robust cash position and manageable debt

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Sustainable dividend with comfortable payout ratio
  • Diversified geographic footprint reduces concentration risk
  • Low beta and stable insurance fundamentals support resilience

Key Metrics & Analysis

Financial Health

Revenue Growth12.10%
Profit Margin20.04%
P/E Ratio15.1
ROE12.56%
ROA0.59%
Debt/Equity44.28
P/B Ratio1.8
Op. Cash FlowCA$28.8B
Free Cash FlowCA$5.5B
Industry P/E16.6

Technical Analysis

TrendBullish
RSI46.4
SupportCA$50.74
ResistanceCA$55.34
MA 20CA$53.36
MA 50CA$51.65
MA 200CA$48.30
MACDBearish
VolumeIncreasing
Fear & Greed Index92.77

Valuation

Fair ValueCA$75.92
Target PriceCA$55.38
Upside/Downside5.99%
GradeUndervalued
TypeBlend
Dividend Yield3.54%

Risk Assessment

Beta0.84
Volatility24.42%
Sector RiskLow
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.